TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets

Adoptive therapy with TCR gene-engineered T cells provides an attractive and feasible treatment option for cancer patients. Further development of TCR gene therapy requires the implementation of T-cell target epitopes that prevent “on-target” reactivity towards healthy tissues and at the same time d...

Descripción completa

Detalles Bibliográficos
Autores principales: Straetemans, Trudy, van Brakel, Mandy, van Steenbergen, Sabine, Broertjes, Marieke, Drexhage, Joost, Hegmans, Joost, Lambrecht, Bart N., Lamers, Cor, Bruggen, Pierre van Der, Coulie, Pierre G., Debets, Reno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287115/
https://www.ncbi.nlm.nih.gov/pubmed/22400038
http://dx.doi.org/10.1155/2012/586314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287115/
https://www.ncbi.nlm.nih.gov/pubmed/22400038
http://dx.doi.org/10.1155/2012/586314

Ejemplares similares